MBX Biosciences (MBX) Accumulated Depreciation (2023 - 2026)
MBX Biosciences (MBX) reported Accumulated Depreciation of $734000.0 for Q1 2026, up 47.09% on a YoY basis from $499000.0 in Q1 2025, and up 9.55% sequentially from $670000.0 in Q4 2025.
MBX Biosciences (MBX) Accumulated Depreciation (2023 - 2026) Analysis & Trends
MBX Biosciences (MBX) has 4 years of Accumulated Depreciation data on file, last reported at $734000.0 in Q1 2026.
- For the quarter ending Q1 2026, Accumulated Depreciation rose 47.09% year-over-year to $734000.0; the trailing twelve-month figure through Mar 2026 stood at $734000.0 (up 47.09% YoY), and the FY2025 full-year result was $670000.0, up 58.77% from the prior year.
- Accumulated Depreciation advanced to $734000.0 in Q1 2026, from $670000.0 in the prior quarter.
- In the past five years, Accumulated Depreciation ranged from a high of $734000.0 in Q1 2026 to a low of $178000.0 in Q4 2023.
- A 4-year average of $504625.0 and a median of $529500.0 in 2025 frame the typical range for Accumulated Depreciation.
- Across the five-year window, Accumulated Depreciation surged 137.08% in 2024 and surged 47.09% in 2026, its largest moves.
- Tracing MBX's Accumulated Depreciation over 4 years: stood at $178000.0 in 2023, then surged by 137.08% to $422000.0 in 2024, then surged by 58.77% to $670000.0 in 2025, then rose by 9.55% to $734000.0 in 2026.
- Business Quant data shows MBX's Accumulated Depreciation at $734000.0 in Q1 2026, $670000.0 in Q4 2025, and $610000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | MBX Biosciences | 2.96 Bn | 2.96 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 734,000.00 |
| Dec 31, 2025 | 670,000.00 |
| Sep 30, 2025 | 610,000.00 |
| Jun 30, 2025 | 560,000.00 |
| Mar 31, 2025 | 499,000.00 |
| Dec 31, 2024 | 422,000.00 |
| Sep 30, 2024 | 364,000.00 |
| Dec 31, 2023 | 178,000.00 |